Navigation Links
Health Economics Research Institute Call for Proposals--Improving Healthcare Through Market Solutions
Date:4/27/2009

NORTHBROOK, Ill., April 27 /PRNewswire-USNewswire/ -- The Health Economics Research Institute (HERI) is actively pursuing research proposals to support its mission of improving the U.S. health care delivery system through market-based solutions. Critical to its efforts: Exploring and testing better ways to organize and finance the system in order to improve patient care.

Lee Stillwell, HERI's chair, said, "We are interested in identifying projects that demonstrate market-based solutions to health care reform, such as developing/testing new models to improve access to care, exploring innovative system changes needed to improve care, and building coalitions to support/advance improved health care access."

In addition, with health information technology a top priority of President Obama's health care reform initiative, "we are particularly interested in projects that explore the numerous issues involved with successful implementation and use of digital health data to improve patient care and system efficiency," Stillwell said.

Projects that HERI is looking to support may include, but will not be limited to:

  • Standards and training
  • Technology selection
  • System interoperability
  • Patient privacy
  • Cost

Interested applicants should submit a brief proposal to nancy.macrae@healtheconomicsresearchinstitute.org. HERI will work to secure funding support for projects selected.

HERI is a non-profit, tax-exempt organization under the provisions of Section 501-C(3) of the Internal Revenue Code and registered in the State of Delaware. For more
'/>"/>

SOURCE Health Economics Research Institute
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Medgateway.com Provides a Gateway to Reliable Health and Medical Information on the Internet.
2. Navigate Global Health to Provide Medical Travel Services to Acibadem Healthcare Group Hospitals in Turkey
3. Galen Healthcare Solutions Launches Electronic Health Record Downtime Solution
4. U.S. Declares Public Health Emergency in Response to Swine Flu
5. Honeywell LifeStream(TM) Products Improve Patient Care by Offering Greater Access to Web-Based Health Information
6. HookUp: Sexual Health Info Text Messaging Service for California Youth Launches
7. United American Healthcare Corporation to Host Fiscal 2009 Third Quarter Results Conference Call May 7th
8. Combat Duty Harms Long-Term Health of Vets
9. New target for maintaining healthy blood pressure discovered
10. Landmark study demonstrates Gamunex improves health-related quality of life in patients with CIDP
11. Free Health, Dental and Vision Screenings at Hamilton Health Center on May 2 Will Help Harrisburg Area Children and Adults
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 2Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 3Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 4Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 5Stallergenes: Oralair: Very Positive 3-Year Results of the Long-Term Study 2Stallergenes: Oralair: Very Positive 3-Year Results of the Long-Term Study 3Stallergenes: Oralair: Very Positive 3-Year Results of the Long-Term Study 4Stallergenes: Oralair: Very Positive 3-Year Results of the Long-Term Study 5Q-Med AB and Oceana Therapeutics, Inc. Take Major Step Towards SOLESTA(TM) US Regulatory Filing 2Q-Med AB and Oceana Therapeutics, Inc. Take Major Step Towards SOLESTA(TM) US Regulatory Filing 3Want to Stop Cancer 3F You Can Experts Say 47763 1Want to Stop Cancer 3F You Can Experts Say 47763 2Want to Stop Cancer 3F You Can Experts Say 47763 3New Ad Campaign Asks D C Commuters Whos Hogging Our Antibiotics 3F 47760 1New Ad Campaign Asks D C Commuters Whos Hogging Our Antibiotics 3F 47760 2Lilly Resubmits Cymbalta 28R 29 Supplemental New Drug Application for Chronic Pain to U S Food and Drug Administration 47758 1Lilly Resubmits Cymbalta 28R 29 Supplemental New Drug Application for Chronic Pain to U S Food and Drug Administration 47758 2Lilly Resubmits Cymbalta 28R 29 Supplemental New Drug Application for Chronic Pain to U S Food and Drug Administration 47758 3Lilly Resubmits Cymbalta 28R 29 Supplemental New Drug Application for Chronic Pain to U S Food and Drug Administration 47758 4